The capacity of apoB-depleted serum to prevent LDLs from oxidation was reduced in 30 patients with T1D in comparison to 30 non-diabetic individuals, without any effect related to glycaemic control in this study [47]. Here, APOB is linked to type 1 diabetes mellitus.